PathoGenetiX Adds $4M in VC
Woburn, Mass.-based PathoGenetiX Inc., a developer of genome sequence scanning technology, has raised $4 million in a first close of its Series B financing. Excel Venture Management led the round, which also included investments from CB Health Ventures and HealthCare Ventures. The company has sealed commitments for $9.5 million in total Series B financing.
1 August 2011•3 mins read
